APA (7th ed.) Citation

Y, A., N, Y., C, S., S, O., A, T., A, N., . . . S, Y. (2020). Reduced doses of dabrafenib and trametinib combination therapy for BRAF V600E-mutant non-small cell lung cancer prevent rhabdomyolysis and maintain tumor shrinkage: A case report. BMC cancer, 20(1), 156. https://doi.org/10.1186/s12885-020-6626-9

Chicago Style (17th ed.) Citation

Y, Adachi, et al. "Reduced Doses of Dabrafenib and Trametinib Combination Therapy for BRAF V600E-mutant Non-small Cell Lung Cancer Prevent Rhabdomyolysis and Maintain Tumor Shrinkage: A Case Report." BMC Cancer 20, no. 1 (2020): 156. https://doi.org/10.1186/s12885-020-6626-9.

MLA (9th ed.) Citation

Y, Adachi, et al. "Reduced Doses of Dabrafenib and Trametinib Combination Therapy for BRAF V600E-mutant Non-small Cell Lung Cancer Prevent Rhabdomyolysis and Maintain Tumor Shrinkage: A Case Report." BMC Cancer, vol. 20, no. 1, 2020, p. 156, https://doi.org/10.1186/s12885-020-6626-9.